18 participants
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2023-08-30
- Completion:
- 2027-04-01
Conditions
- Frontotemporal Dementia
- FTD
- FTD-GRN
- Dementia, Frontotemporal
Interventions
- PROCEDURE
- GENETIC
No Results Yet